{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:42:57Z","timestamp":1776883377687,"version":"3.51.2"},"reference-count":74,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.oftale.2024.04.008","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T16:32:16Z","timestamp":1713889936000},"page":"331-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological treatments for the correction of presbyopia"],"prefix":"10.1016","volume":"99","author":[{"given":"H.","family":"Fern\u00e1ndez Jim\u00e9nez-Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Toledano Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2024.04.008_bib0005","first-page":"12","article-title":"Restoration of accommodation","volume":"17","author":"Glasser","year":"2006","journal-title":"Curr Opin Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0010","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","article-title":"Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: systematic review, meta-analysis, and modelling","volume":"125","author":"Fricke","year":"2018","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftale.2024.04.008_bib0015","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/OPTH.S259011","article-title":"Presbyopia - a review of current treatment options and emerging therapies","volume":"15","author":"Katz","year":"2021","journal-title":"Clin Ophthalmol Auckl NZ."},{"key":"10.1016\/j.oftale.2024.04.008_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09286586.2019.1700532","article-title":"Thirty year projected magnitude (to 2050) of near and distance vision impairment and the economic impact if existing solutions are implemented globally","volume":"27","author":"Bastawrous","year":"2020","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.visres.2004.07.032","article-title":"Change in shape of the aging human crystalline lens with accommodation","volume":"45","author":"Dubbelman","year":"2005","journal-title":"Vision Res."},{"key":"10.1016\/j.oftale.2024.04.008_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000027475","article-title":"The ageing lens","volume":"214","author":"Bron","year":"2000","journal-title":"Ophthalmologica."},{"key":"10.1016\/j.oftale.2024.04.008_bib0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICU.0000000000000770","article-title":"Pharmacological strategies for treating presbyopia","volume":"32","author":"Orman","year":"2021","journal-title":"Curr Opin Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004397-200104000-00003","article-title":"Aging of the human crystalline lens and presbyopia","volume":"41","author":"Glasser","year":"2001","journal-title":"Int Ophthalmol Clin."},{"key":"10.1016\/j.oftale.2024.04.008_bib0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004397-200604630-00006","article-title":"The mechanism of accommodation and presbyopia","volume":"46","author":"Schachar","year":"2006","journal-title":"Int Ophthalmol Clin."},{"key":"10.1016\/j.oftale.2024.04.008_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0b013e31815eb836","article-title":"Equatorial lens growth predicts the age-related decline in accommodative amplitude that results in presbyopia and the increase in intraocular pressure that occurs with age","volume":"48","author":"Schachar","year":"2008","journal-title":"Int Ophthalmol Clin."},{"key":"10.1016\/j.oftale.2024.04.008_bib0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00006324-200004000-00013","article-title":"Age-related changes in human ciliary muscle","volume":"77","author":"Pardue","year":"2000","journal-title":"Optom Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0060","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1167\/iovs.10-5787","article-title":"In vivo analysis of ciliary muscle morphologic changes with accommodation and axial ametropia","volume":"51","author":"Sheppard","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jcrs.2009.08.029","article-title":"Magnetic resonance imaging of the anteroposterior position and thickness of the aging, accommodating, phakic, and pseudophakic ciliary muscle","volume":"36","author":"Strenk","year":"2010","journal-title":"J Cataract Refract Surg."},{"key":"10.1016\/j.oftale.2024.04.008_bib0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0014-4835(92)90015-K","article-title":"Protein-thiol mixed disulfides in human lens","volume":"55","author":"Lou","year":"1992","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.oftale.2024.04.008_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.preteyeres.2017.04.001","article-title":"The lens growth process","volume":"60","author":"Bassnett","year":"2017","journal-title":"Prog Retin Eye Res."},{"key":"10.1016\/j.oftale.2024.04.008_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/8.4.29","article-title":"Age-related changes in optical and biometric characteristics of emmetropic eyes","volume":"8","author":"Atchison","year":"2008","journal-title":"J Vis."},{"key":"10.1016\/j.oftale.2024.04.008_bib0085","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1167\/iovs.07-1443","article-title":"In vivo study of changes in refractive index distribution in the human crystalline lens with age and accommodation","volume":"49","author":"Kasthurirangan","year":"2008","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/OPX.0000000000000757","article-title":"The effect of age, accommodation, and refractive error on the adult human eye","volume":"93","author":"Richdale","year":"2016","journal-title":"Optom Vis Sci."},{"issue":"Pt 1","key":"10.1016\/j.oftale.2024.04.008_bib0095","first-page":"83","article-title":"The development and maintenance of emmetropia","volume":"13","author":"Brown","year":"1999","journal-title":"Eye Lond Engl."},{"key":"10.1016\/j.oftale.2024.04.008_bib0100","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13797","article-title":"Aggrelyte-2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: implications for treating presbyopia","volume":"22","author":"Panja","year":"2023","journal-title":"Aging Cell."},{"key":"10.1016\/j.oftale.2024.04.008_bib0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1196\/annals.1338.066","article-title":"The maillard reaction in eye diseases","volume":"1043","author":"Stitt","year":"2005","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0110","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1167\/iovs.15-18413","article-title":"Protein disulfide levels and lens elasticity modulation: applications for presbyopia","volume":"57","author":"Garner","year":"2016","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0115","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms22083841","article-title":"A potential role for fructosamine-3-kinase in cataract treatment","volume":"22","author":"De Bruyne","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1167\/iovs.02-0256","article-title":"Polymer refilling of presbyopic human lenses in vitro restores the ability to undergo accommodative changes","volume":"44","author":"Koopmans","year":"2003","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0125","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/ijms24032196","article-title":"Promotion of protein solubility and reduction in stiffness in human lenses by aggrelyte-1: implications for reversing presbyopia","volume":"24","author":"Panja","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0130","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1074\/jbc.RA120.012604","article-title":"Glycation-mediated inter-protein cross-linking is promoted by chaperone-client complexes of \u03b1-crystallin: implications for lens aging and presbyopia","volume":"295","author":"Nandi","year":"2020","journal-title":"J Biol Chem."},{"key":"10.1016\/j.oftale.2024.04.008_bib0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/mmr.2023.12990","article-title":"Hesperetin treatment attenuates glycation of lens proteins and advanced-glycation end products generation","volume":"27","author":"Doki","year":"2023","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.oftale.2024.04.008_bib0140","series-title":"Borish\u2019s clinical refraction","first-page":"77","article-title":"Accommodation, the pupil and presbyopia","author":"Cuiffreda","year":"1998"},{"key":"10.1016\/j.oftale.2024.04.008_bib0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00006324-198607000-00012","article-title":"Questioning our classical understanding of accommodation and presbyopia","volume":"63","author":"Adler-Grinberg","year":"1986","journal-title":"Am J Optom Physiol Opt."},{"key":"10.1016\/j.oftale.2024.04.008_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cxo.12987","article-title":"Correction of presbyopia: old problems with old (and new) solutions","volume":"103","author":"Kollbaum","year":"2020","journal-title":"Clin Exp Optom."},{"key":"10.1016\/j.oftale.2024.04.008_bib0155","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00417-002-0551-2","article-title":"Monitoring accommodative ciliary muscle function using three-dimensional ultrasound","volume":"240","author":"Stachs","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.preteyeres.2004.11.001","article-title":"The mechanism of presbyopia","volume":"24","author":"Strenk","year":"2005","journal-title":"Prog Retin Eye Res."},{"key":"10.1016\/j.oftale.2024.04.008_bib0165","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s00417-017-3801-z","article-title":"Ocular anatomic changes for different accommodative demands using swept-source optical coherence tomography: a pilot study","volume":"255","author":"Esteve-Taboada","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.visres.2012.09.009","article-title":"Axial length and choroidal thickness changes accompanying prolonged accommodation in myopes and emmetropes","volume":"72","author":"Woodman","year":"2012","journal-title":"Vis Res."},{"key":"10.1016\/j.oftale.2024.04.008_bib0175","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1442-9071.2012.02863.x","article-title":"Evaluation of corneal changes with accommodation in young and presbyopic populations using Pentacam High Resolution Scheimpflug system","volume":"41","author":"Ni","year":"2013","journal-title":"Clin Experiment Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/OPTH.S278169","article-title":"Phentolamine Mesylate ophthalmic solution provides lasting pupil modulation and improves near visual acuity in presbyopic glaucoma patients in a randomized phase 2b clinical trial","volume":"15","author":"Pepose","year":"2021","journal-title":"Clin Ophthalmol Auckl NZ."},{"key":"10.1016\/j.oftale.2024.04.008_bib0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/ICU.0000000000000864","article-title":"Pilocarpine 1.25% and the changing landscape of presbyopia treatment","volume":"33","author":"Meghpara","year":"2022","journal-title":"Curr Opin Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2022.0059","article-title":"Safety and efficacy of AGN-190584 in individuals with presbyopia: the GEMINI 1 phase 3 randomized clinical trial","volume":"140","author":"Waring","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajo.2023.05.008","article-title":"Safety and efficacy of twice-daily pilocarpine HCl in presbyopia: the Virgo Phase 3, randomized, double-masked, controlled study","volume":"253","author":"Kannarr","year":"2023","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0200","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/ICL.0000000000000137","article-title":"Improved presbyopic vision with miotics","volume":"41","author":"Abdelkader","year":"2015","journal-title":"Eye Contact Lens."},{"key":"10.1016\/j.oftale.2024.04.008_bib0205","unstructured":"Clinicaltrials.gov. A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia [Internet]. 2023. [Accessed 7 Dec 2023]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03885011?cond=Presbyopia&distance=50&ageRange=40y_100y&aggFilters=results:with,status:com%20ter,studyType:int&rank=6."},{"key":"10.1016\/j.oftale.2024.04.008_bib0210","unstructured":"Clinicaltrials.gov. A single-center, double-masked evaluation of the efficacy and safety of PRX-100 in the treatment of early to moderate presbyopia. 2017."},{"key":"10.1016\/j.oftale.2024.04.008_bib0215","unstructured":"Clinicialtrials.gov. A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. [Internet]. [Accessed 3 Oct 2023]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03809611?cond=Presbyopia&distance=50&ageRange=40y_100y&aggFilters=results:with,status:com%20ter,studyType:int&rank=4."},{"key":"10.1016\/j.oftale.2024.04.008_bib0220","unstructured":"Clinicaltrials.gov. A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia [Internet]. [Accessed 5 Oct 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02516306?term=UNR844&draw=2&rank=3."},{"key":"10.1016\/j.oftale.2024.04.008_bib0225","first-page":"3292","article-title":"Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial","volume":"35","author":"Korenfeld","year":"2021","journal-title":"Eye Lond Engl."},{"key":"10.1016\/j.oftale.2024.04.008_bib0230","first-page":"2507","article-title":"VEGA-1 phase 2 trial: phentolamine ophthalmic solution maintains pupillary","volume":"64","author":"Patel","year":"2023","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0235","first-page":"1813","article-title":"VEGA-1: phentolamine ophthalmic solution as a single agent improves distance-corrected near visual acuity in patients with presbyopia","volume":"63","author":"Katz","year":"2022","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0240","unstructured":"Clinicaltrials.gov. Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) With Pilocarpine Eye Drops in Subjects With Presbyopia [Internet]. [Accessed 5 Oct 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04675151?recrs=eh&rslt=With&type=Intr&cond=presbyopia&age_v=40&draw=3&rank=1."},{"key":"10.1016\/j.oftale.2024.04.008_bib0245","article-title":"The efficacy of phentolamine ophthalmic solution and low-dose pilocarpine to improve distance-corrected intermediate visual acuity in patients with presbyopia","author":"Pepose","year":"2022","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0250","first-page":"5423","article-title":"Phentolamine ophthalmic solution, with and without low dose pilocarpine, provides durable improvement in distance corrected near vision in presbyopic patients: a responder analysis","volume":"64","author":"Brigell","year":"2023","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0255","unstructured":"Clinicaltrials.gov. A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia [Internet]. [Accessed 5 Oct 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/study\/NCT02595528?recrs=eh&rslt=With&type=Intr&cond=presbyopia&age_v=40&draw=3&rank=5."},{"key":"10.1016\/j.oftale.2024.04.008_bib0260","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.4081\/ejtm.2022.10781","article-title":"Pharmacological treatment of presbyopia: a systematic review","volume":"32","author":"Haghpanah","year":"2022","journal-title":"Eur J Transl Myol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/APO.0000000000000297","article-title":"A review of pharmacological presbyopia treatment","volume":"9","author":"Grzybowski","year":"2020","journal-title":"Asia-Pac J Ophthalmol Phila Pa."},{"key":"10.1016\/j.oftale.2024.04.008_bib0270","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/opo.12995","article-title":"Pharmacological treatment of presbyopia","volume":"42","author":"Rosenfield","year":"2022","journal-title":"Ophthalmic Physiol Opt."},{"key":"10.1016\/j.oftale.2024.04.008_bib0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40266-022-01002-4","article-title":"Pharmacological treatments for presbyopia","volume":"40","author":"Orman","year":"2023","journal-title":"Drugs Aging."},{"issue":"S1","key":"10.1016\/j.oftale.2024.04.008_bib0280","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3928\/1081597X-20210408-04","article-title":"Advances in corneal surgical and pharmacological approaches to the treatment of presbyopia","volume":"37","author":"McDonald","year":"2021","journal-title":"J Refract Surg."},{"issue":"S1","key":"10.1016\/j.oftale.2024.04.008_bib0285","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.3928\/1081597X-20210408-06","article-title":"Future trends in presbyopia correction","volume":"37","author":"Mercer","year":"2021","journal-title":"J Refract Surg."},{"key":"10.1016\/j.oftale.2024.04.008_bib0290","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3928\/1081597X-20191010-04","article-title":"Pharmacological strategies for presbyopia correction","volume":"35","author":"Mont\u00e9s-Mic\u00f3","year":"2019","journal-title":"J Refract Surg."},{"key":"10.1016\/j.oftale.2024.04.008_bib0295","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/OPX.0000000000001924","article-title":"Topical review: pilocarpine-induced miosis as help for early presbyopes?","volume":"99","author":"Westheimer","year":"2022","journal-title":"Optom Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0300","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3390\/nu14235014","article-title":"Nutraceuticals: a promising therapeutic approach in ophthalmology","volume":"14","author":"Castro-Castaneda","year":"2022","journal-title":"Nutrients."},{"key":"10.1016\/j.oftale.2024.04.008_bib0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/j.jcrs.0000000000001313","article-title":"Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: a pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2)","volume":"50","author":"Lievens","year":"2024","journal-title":"J Cataract Refract Surg."},{"key":"10.1016\/j.oftale.2024.04.008_bib0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40662-017-0068-8","article-title":"Pharmacological treatments of presbyopia: a review of modern perspectives","volume":"4","author":"Renna","year":"2017","journal-title":"Eye Vis Lond Engl."},{"key":"10.1016\/j.oftale.2024.04.008_bib0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-4835(90)90224-I","article-title":"Dissociation between the effect of aceclidine on outflow facility and accommodation","volume":"50","author":"Erickson-Lamy","year":"1990","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.oftale.2024.04.008_bib0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajo.2022.05.011","article-title":"Retinal detachments associated with topical pilocarpine use for presbyopia","volume":"242","author":"Al-Khersan","year":"2022","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0325","article-title":"A unique drop [Internet]","author":"Lipner","year":"2014","journal-title":"EyeWorld."},{"key":"10.1016\/j.oftale.2024.04.008_bib0330","unstructured":"Clinicaltrials.gov. A safety, efficacy and pharmacokinetic study of AGN-199201 and AGN-190584 in patients with presbyopia. [Internet]. 2017. [Accessed 5 Dec 2023]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02780115."},{"key":"10.1016\/j.oftale.2024.04.008_bib0335","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/ICU.0000000000000969","article-title":"Challenges and controversies in ophthalmology in 2023","volume":"34","author":"Weng","year":"2023","journal-title":"Curr Opin Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0340","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ophtha.2015.04.014","article-title":"The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia","volume":"122","author":"Frick","year":"2015","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftale.2024.04.008_bib0345","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/OPX.0000000000001913","article-title":"Exploring the experience of living with and managing presbyopia","volume":"99","author":"Stokes","year":"2022","journal-title":"Optom Vis Sci."},{"key":"10.1016\/j.oftale.2024.04.008_bib0350","first-page":"3","article-title":"Presbyopia: a new potential pharmacological treatment","volume":"1","author":"Benozzi","year":"2012","journal-title":"Med Hypothesis Discov Innov Ophthalmol J."},{"key":"10.1016\/j.oftale.2024.04.008_bib0355","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00417-021-05138-8","article-title":"A multicentric study of pharmacological treatment for presbyopia","volume":"259","author":"Benozzi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0360","first-page":"25","article-title":"Presbyopia treatment with eye drops: an eight year retrospective study","volume":"9","author":"Benozzi","year":"2020","journal-title":"Transl Vis Sci Technol."},{"key":"10.1016\/j.oftale.2024.04.008_bib0365","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ICB.0000000000001309","article-title":"Rhegmatogenous retinal detachment following initiation of pilocarpine hydrochloride ophthalmic solution 1.25% for treatment of presbyopia","volume":"18","author":"Eton","year":"2024","journal-title":"Retin Cases Brief Rep."},{"key":"10.1016\/j.oftale.2024.04.008_bib0370","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1167\/iovs.12-10847","article-title":"Accommodative movements of the vitreous membrane, choroid, and sclera in young and presbyopic human and nonhuman primate eyes","volume":"54","author":"Croft","year":"2013","journal-title":"Invest Ophthalmol Vis Sci."}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579424000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579424000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T22:15:30Z","timestamp":1731795330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579424000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2173579424000707"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2024.04.008","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatments for the correction of presbyopia","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2024.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2024.03.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}